Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial

被引:0
|
作者
Annelie Liljegren
Pia Gunnarsson
Britt-Marie Landgren
Ninna Robéus
Hemming Johansson
Samuel Rotstein
机构
[1] Radiumhemmet,Department of Oncology
[2] Karolinska University Hospital and Karolinska Institutet,Department of Physiotherapy
[3] Karolinska University Hospital,Department of Gynecology
[4] Karolinska University Hospital and Karolinska Institutet,Department of Oncology
[5] Gynekologmottagningen Mörby Centrum Danderyd,Department of Oncology
[6] Karolinska University Hospital,undefined
[7] Karolinska University Hospital and Karolinska Institutet,undefined
来源
关键词
Acupuncture; Sham; Hot flush; Breast cancer; Adjuvant; Tamoxifen;
D O I
暂无
中图分类号
学科分类号
摘要
To evaluate true acupuncture to control acupuncture (CTRL) (non-insertive stimulation at non-acupuncture points) in breast cancer patients treated with adjuvant tamoxifen suffering from hot flushes and sweatings. Eighty-four patients were randomized to receive either true acupuncture or CTRL twice a week for 5 weeks. Seventy-four patients were treated according to the protocol. In the true acupuncture group 42% (16/38) reported improvements in hot flushes after 6 weeks compared to 47% (17/36) in the CTRL group (95% CI, −28 to 18%). Both groups reported improvement regarding severity and frequencies in hot flushes and sweatings but no statistical difference was found between the groups. In a subanalysis regarding the severity of sweatings at night a statistically significant difference P = 0.03 was found in the true acupuncture group. Former experience of true acupuncture did not influence the perception of true acupuncture or CTRL. No significant differences in hormonal levels were found before and after treatment. In conclusion, convincing data that true acupuncture is more effective than CTRL in reducing vasomotor symptoms is still lacking. Our study shows that both true and CTRL reduce vasomotor symptoms in breast cancer patients treated with adjuvant tamoxifen.
引用
收藏
页码:791 / 798
页数:7
相关论文
共 50 条
  • [1] Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial
    Liljegren, Annelie
    Gunnarsson, Pia
    Landgren, Britt-Marie
    Robeus, Ninna
    Johansson, Hemming
    Rotstein, Samuel
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 791 - 798
  • [2] Impact of Acupuncture on Hot Flashes in Breast Cancer Patients Receiving Adjuvant Antiestrogen Therapy with Tamoxifen: A Randomized Controlled Trial
    Jeong, Young Ju
    Choi, Hye Ryeon
    Kim, Kyung-Soon
    Shin, Im Hee
    Park, Sung Hwan
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2023, 29 (04): : 241 - 252
  • [3] Acupuncture Versus Venlafaxine for the Management of Vasomotor Symptoms in Patients With Hormone Receptor-Positive Breast Cancer: A Randomized Controlled Trial
    Walker, Eleanor M.
    Rodriguez, Alba I.
    Kohn, Beth
    Ball, Ronald M.
    Pegg, Jan
    Pocock, Jeffrey R.
    Nunez, Ramon
    Peterson, Ed
    Jakary, Susan
    Levine, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 634 - 640
  • [4] Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
    Arriagada, R
    Spielmann, M
    Koscielny, S
    Le Chevalier, T
    Delozier, T
    Ducourtieux, M
    Tursz, T
    Hill, C
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1378 - 1386
  • [5] Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial
    Hervik, Jill
    Mjaland, Odd
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (02) : 311 - 316
  • [6] Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial
    Jill Hervik
    Odd Mjåland
    Breast Cancer Research and Treatment, 2009, 116
  • [7] Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients
    Deng, Gary
    Vickers, Andrew J.
    Yeung, K. Simon
    D'Andrea, Gabriella M.
    Xiao, Han
    Heerdt, Alexandra S.
    Sugarman, Steven
    Troso-Sandoval, Tiffany
    Seidman, Andrew D.
    Hudis, Clifford A.
    Cassileth, Barrie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) : 5584 - 5590
  • [8] A MULTICENTER PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF ADJUVANT NOLVADEX (TAMOXIFEN) THERAPY IN EARLY BREAST-CANCER
    WILSON, AJ
    BAUM, M
    BRINKLEY, D
    DOSSETT, JA
    MCPHERSON, K
    RUBENS, RD
    STOLL, BA
    SMIDDY, FG
    PATTERSON, J
    BARNES, DM
    HOLDAWAY, IM
    KING, R
    LEAKE, R
    NICHOLSON, R
    LEA, J
    ELLIS, S
    RICHARDS, D
    BRITISH JOURNAL OF SURGERY, 1982, 69 (11) : 688 - 688
  • [9] CONTRALATERAL PRIMARY TUMORS IN BREAST-CANCER PATIENTS IN A RANDOMIZED TRIAL OF ADJUVANT TAMOXIFEN THERAPY
    RUTQVIST, LE
    CEDERMARK, B
    GLAS, U
    MATTSSON, A
    SKOOG, L
    SOMELL, A
    THEVE, T
    WILKING, N
    ASKERGREN, J
    HJALMAR, ML
    ROTSTEIN, S
    PERBECK, L
    RINGBORG, U
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (18) : 1299 - 1306
  • [10] Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
    Johansson, Annelie
    Dar, Huma
    Veer, Laura J. van 't
    Tobin, Nicholas P.
    Perez-Tenorio, Gizeh
    Nordenskjold, Anna
    Johansson, Ulla
    Hartman, Johan
    Skoog, Lambert
    Yau, Christina
    Benz, Christopher C.
    Esserman, Laura J.
    Stal, Olle
    Nordenskjold, Bo
    Fornander, Tommy
    Lindstrom, Linda S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (35) : 4071 - 4082